Webinar date: June 10, 2021 at 4:00PM EST
This Journal Club was sponsored by the Assembly on Allergy, Immunology, and Inflammation (AII) and featured the findings from the NAVIGATOR Phase III trial studying tezepelumab anti-TSLP therapy in patients with severe asthma.
Presenter:
Andrew Menzies-Gow, BSc, MB BS, PhD, FRCP, Director of the Lung Division, Royal Brompton Hospital, London UK, Professor of Respiratory Medicine, National Heart and Lung Institute, Imperial College, London, UK and National Clinical Director for Respiratory Disease, NHS England
Gene Colice, MD, Respiratory and Immunology, BioPharmeceuticals R&D, AstraZeneca, Gaithersburg, MD, USA
Discussant Panelists:
Benjamin Medoff, MD, Associate Professor of Medicine, Massachusetts General Hospital, Harvard Medical School
Clare Lloyd, PhD, FRSB, FMedSci, Wellcome Senior Research Fellow in Basic Biomedical Sciences, Professor of Respiratory Immunology, Head of the Division of Respiratory Sciences at the National Heart and Lung Institute, and Vice Dean for Institutional Affairs in the Faculty of Medicine, Imperial College, London, UK
Moderator:
Jehan Alladina, MD, Instructor in Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA
